- Page 1 and 2: ISSN 1007-9327 (print)ISSN 2219-284
- Page 3 and 4: Phillip S Oates, PerthRoss C Smith,
- Page 5 and 6: Deepak N Amarapurkar, MumbaiAbhijit
- Page 7 and 8: Trine Olsen, TromsøEyvind J Paulss
- Page 9: Conor P Delaney, ClevelandSharon De
- Page 13: ContentsWorld Journal of Gastroente
- Page 16 and 17: Korelitz BI. 6-MP in the treatment
- Page 18 and 19: Korelitz BI. 6-MP in the treatment
- Page 20: Korelitz BI. 6-MP in the treatment
- Page 23 and 24: Raisch J et al . MicroRNAs in immun
- Page 25 and 26: Raisch J et al . MicroRNAs in immun
- Page 27 and 28: Raisch J et al . MicroRNAs in immun
- Page 29 and 30: Raisch J et al . MicroRNAs in immun
- Page 31 and 32: Raisch J et al . MicroRNAs in immun
- Page 33 and 34: Online Submissions: http://www.wjgn
- Page 35 and 36: Puglisi MA et al . Colon cancer ste
- Page 37 and 38: Puglisi MA et al . Colon cancer ste
- Page 39 and 40: Puglisi MA et al . Colon cancer ste
- Page 41 and 42: Puglisi MA et al . Colon cancer ste
- Page 43 and 44: Online Submissions: http://www.wjgn
- Page 45 and 46: Grattagliano I et al . Silybin and
- Page 47 and 48: Grattagliano I et al . Silybin and
- Page 49 and 50: Grattagliano I et al . Silybin and
- Page 51 and 52: Grattagliano I et al . Silybin and
- Page 53 and 54: Grattagliano I et al . Silybin and
- Page 55 and 56: Spanier BWM et al . Epidemiology ac
- Page 57 and 58: Spanier BWM et al . Epidemiology ac
- Page 59 and 60: Spanier BWM et al . Epidemiology ac
- Page 61 and 62:
Spanier BWM et al . Epidemiology ac
- Page 63 and 64:
Online Submissions: http://www.wjgn
- Page 65 and 66:
Ohashi N et al . MMP-9 after extend
- Page 67 and 68:
Ohashi N et al . MMP-9 after extend
- Page 69 and 70:
Ohashi N et al . MMP-9 after extend
- Page 71 and 72:
Ohashi N et al . MMP-9 after extend
- Page 73 and 74:
Ohashi N et al . MMP-9 after extend
- Page 75 and 76:
Ohashi N et al . MMP-9 after extend
- Page 77 and 78:
Ohashi N et al . MMP-9 after extend
- Page 79 and 80:
Online Submissions: http://www.wjgn
- Page 81 and 82:
Alvarez MC et al . Methylation and
- Page 83 and 84:
Alvarez MC et al . Methylation and
- Page 85 and 86:
Alvarez MC et al . Methylation and
- Page 87 and 88:
Alvarez MC et al . Methylation and
- Page 89 and 90:
Musio D et al . Neoadjuvant-intensi
- Page 91 and 92:
Musio D et al . Neoadjuvant-intensi
- Page 93 and 94:
Musio D et al . Neoadjuvant-intensi
- Page 95 and 96:
Musio D et al . Neoadjuvant-intensi
- Page 97 and 98:
Musio D et al . Neoadjuvant-intensi
- Page 99 and 100:
Horvath A et al . Glucomannan for f
- Page 101 and 102:
Horvath A et al . Glucomannan for f
- Page 103 and 104:
Horvath A et al . Glucomannan for f
- Page 105 and 106:
Online Submissions: http://www.wjgn
- Page 107 and 108:
Kim YD et al . Sodium hyaluronate f
- Page 109 and 110:
Kim YD et al . Sodium hyaluronate f
- Page 111 and 112:
Kim YD et al . Sodium hyaluronate f
- Page 113 and 114:
Online Submissions: http://www.wjgn
- Page 115 and 116:
Kim JH et al . Robotic cholecystect
- Page 117 and 118:
Kim JH et al . Robotic cholecystect
- Page 119 and 120:
Online Submissions: http://www.wjgn
- Page 121 and 122:
Cheung TT et al . HIFU ablation bef
- Page 123 and 124:
Cheung TT et al . HIFU ablation bef
- Page 125 and 126:
Cheung TT et al . HIFU ablation bef
- Page 127 and 128:
Zhang MJ et al . Real time PCR for
- Page 129 and 130:
Zhang MJ et al . Real time PCR for
- Page 131 and 132:
Zhang MJ et al . Real time PCR for
- Page 133 and 134:
Ren G et al . Lymph nodes and early
- Page 135 and 136:
Ren G et al . Lymph nodes and early
- Page 137 and 138:
Ren G et al . Lymph nodes and early
- Page 139 and 140:
Ren G et al . Lymph nodes and early
- Page 141 and 142:
Ren G et al . Lymph nodes and early
- Page 143 and 144:
Ren G et al . Lymph nodes and early
- Page 145 and 146:
Jiang ZX et al . Imaging findings o
- Page 147 and 148:
Jiang ZX et al . Imaging findings o
- Page 149 and 150:
Jiang ZX et al . Imaging findings o
- Page 151 and 152:
Jiang ZX et al . Imaging findings o
- Page 153 and 154:
Online Submissions: http://www.wjgn
- Page 155 and 156:
Rong C et al . Synchronous tumors i
- Page 157 and 158:
Rong C et al . Synchronous tumors i
- Page 159 and 160:
Rong C et al . Synchronous tumors i
- Page 161 and 162:
Niu XP et al . PPI refractoriness i
- Page 163 and 164:
Niu XP et al . PPI refractoriness i
- Page 165 and 166:
Niu XP et al . PPI refractoriness i
- Page 167 and 168:
Chen HJ et al . huCdc7 in colorecta
- Page 169 and 170:
Chen HJ et al . huCdc7 in colorecta
- Page 171 and 172:
Lv WS et al . NAFLD and diabetic mi
- Page 173 and 174:
Lv WS et al . NAFLD and diabetic mi
- Page 175 and 176:
Lv WS et al . NAFLD and diabetic mi
- Page 177 and 178:
Lv WS et al . NAFLD and diabetic mi
- Page 179 and 180:
Online Submissions: http://www.wjgn
- Page 181 and 182:
Chen K et al . cfDNA, AFP and AFU i
- Page 183 and 184:
Chen K et al . cfDNA, AFP and AFU i
- Page 185 and 186:
Chen K et al . cfDNA, AFP and AFU i
- Page 187 and 188:
Wang LX et al . Protective effects
- Page 189 and 190:
Wang LX et al . Protective effects
- Page 191 and 192:
Wang LX et al . Protective effects
- Page 193 and 194:
Online Submissions: http://www.wjgn
- Page 195 and 196:
Odagaki T et al . Small undifferent
- Page 197 and 198:
Online Submissions: http://www.wjgn
- Page 199 and 200:
Onishi I et al . IPNB accompanying
- Page 201 and 202:
Online Submissions: http://www.wjgn
- Page 203 and 204:
Maeshima K et al . Behçet’s dise
- Page 205 and 206:
Online Submissions: http://www.wjgn
- Page 207 and 208:
Xie SP et al . Esophageal reconstru
- Page 209 and 210:
Online Submissions: http://www.wjgn
- Page 211 and 212:
Instructions to authorssess any pot
- Page 213 and 214:
Instructions to authorsPMID and DOI
- Page 215:
Published by Baishideng Publishing